Erratum: A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with Coronary Heart Disease (Experimental and Clinical Endocrinology and Diabetes (2017) (125) DOI: 10.1055/s-0042-105441);A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 125, Issue 1, 2017, Pages 21-27

  Tajabadi Ebrahimi, M ^a   Sharifi, N ^b   Farrokhian, A ^b   Raygan, F ^b   Karamali, F ^c   Razzaghi, R ^b   Taheri, S ^b   Asemi, Z ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary heart disease; Metabolic status; Supplementation; Synbiotic; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROBIOTIC AGENT; SYNBIOTIC AGENT; LIPID;

ADULT; ARTICLE; B LYMPHOCYTE; BIFIDOBACTERIUM BIFIDUM; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; ISCHEMIC HEART DISEASE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; MAJOR CLINICAL STUDY; MICROCAPSULE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; AGED; BIFIDOBACTERIUM; BLOOD; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; OVERWEIGHT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIFIDOBACTERIUM; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LIPIDS; MALE; MIDDLE AGED; OVERWEIGHT; PROBIOTICS;

EID: 84969981067     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/a-1736-9432     Document Type: Erratum

References (34)

1. Farrag A, Bakhoum S, Salem MA et al. The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. Heart Vessels 2013; 28: 12-18
2. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393
3. Chillaron JJ, Roux JA, Benaiges D et al. Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen. World J Clin Cases 2014; 2: 415-421
4. Lichtenstein AH, Appel LJ, Brands M et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96
5. DiRienzo DB. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets. Nutr Rev 2014; 72: 18-29
6. Sanders ME. Probiotics: considerations for human health. Nutr Rev 2003; 61: 91-99
7. Roberfroid M, Gibson GR, Hoyles L et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104 (Suppl 2): S1-S63
8. Guarner F, Khan AG, Garisch J et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46: 468-481
9. Cani PD, Everard A. Talking microbes: When gut bacteria interact with diet and host organs. Mol Nutr Food Res 2016; 60: 58-66
10. Vitali B, Ndagijimana M, Cruciani F et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010; 10: 4 doi:10.1186/1471-2180-10-4
11. Tajadadi-Ebrahimi M, Bahmani F, Shakeri H et al. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial. Ann Nutr Metab 2014; 65: 34-41
12. Beserra BT, Fernandes R, do Rosario VA et al. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin Nutr 2015; 34: 845-858
13. Asemi Z, Khorrami-Rad A, Alizadeh SA et al. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014; 33: 198-203
14. Frece J, Kos B, Svetec IK et al. Synbiotic effect of Lactobacillus helveticus M92 and prebiotics on the intestinal microflora and immune system of mice. J Dairy Res 2009; 76: 98-104
15. Worthley DL, Le Leu RK, Whitehall VL et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 2009; 90: 578-586
16. Larsen N, Vogensen FK, van den Berg FW et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5: e9085 doi:10.1371/journal.pone.0009085
17. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl 1): S81-S90
19. Welles CC, Whooley MA, Karumanchi SA et al. Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol 2014; 179: 1279-1287
20. Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-S504
21. Pisprasert V, Ingram KH, Lopez-Davila MF et al. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013; 36: 845-853
22. Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep 2014; 16: 419 doi:10.1007/s11883-014-0419-z Review
23. Eslamparast T, Zamani F, Hekmatdoost A et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr 2014; 112: 438-445
24. Moroti C, Souza Magri LF, de Rezende Costa M et al. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 2012; 11: 29 doi:10.1186/1476-511X-11-29
25. Malaguarnera M, Vacante M, Antic T et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 2012; 57: 545-553
26. Al-Attas OS, Al-Daghri NM, Al-Rubeaan K et al. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol 2009; 8: 20 doi:10.1186/1475-2840-8-20
27. Kellow NJ, Coughlan MT, Savige GS et al. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr Disord 2014; 14: 55 doi:10.1186/1472-6823-14-55
28. Raso GM, Simeoli R, Iacono A et al. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem 2014; 25: 81-90
29. Taghizadeh M, Hashemi T, Shakeri H et al. Synbiotic food consumption reduces levels of triacylglycerols and VLDL, but not cholesterol, LDL, or HDL in plasma from pregnant women. Lipids 2014; 49: 155-161
30. Kiessling G, Schneider J, Jahreisl G. Original Communication. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002; 56: 843-849
31. Greany KA, Bonorden MJ, Hamilton-Reeves JM et al. Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 2008; 62: 232-237
32. Rajkumar H, Kumar M, Das N et al. Effect of probiotic lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: A randomized controlled single-blind pilot study. J Cardiovasc Pharmacol Ther 2015; 20: 289-298
33. Konstantinov SR, Smidt H, de Vos WM et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci USA 2008; 105: 19474-19479
34. Ouwehand AC, Tiihonen K, Saarinen M et al. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 2009; 101: 367-375